Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results

Relay Therapeutics, Inc. (RLAY) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/12/2023 8-K Quarterly results
10/02/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
09/29/2023 4 Patel Sanjiv (President and CEO) has filed a Form 4 on Relay Therapeutics, Inc.
Txns: Granted 1,662 shares @ $10.68, valued at $17.8k
09/29/2023 4 Rahmer Peter (See remarks) has filed a Form 4 on Relay Therapeutics, Inc.
Txns: Granted 1,662 shares @ $10.68, valued at $17.8k
Sold 244 shares @ $8.38, valued at $2k
09/29/2023 4 Catinazzo Thomas (CFO) has filed a Form 4 on Relay Therapeutics, Inc.
Txns: Sold 294 shares @ $8.38, valued at $2.5k
09/29/2023 4 Adams Brian (Chief Legal Officer) has filed a Form 4 on Relay Therapeutics, Inc.
Txns: Sold 294 shares @ $8.38, valued at $2.5k
08/08/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/08/2023 8-K Quarterly results
Docs: "Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Revenue: License and other revenue $ 119 $ 365 $ 345 $ 784 Total revenue 119 365 345 784 Operating expenses: Research and development expenses $ 88,201 $ 60,511 $ 171,028 $ 112,178 Change in fair value of contingent consideration liability 200 General and administrative expenses 20,120 17,465 39,699 33,533 Total operating expenses 106,169 78,176 207,572 141,316 Loss from operations Other income: Interest income 7,559 1,005 14,500 1,701 Other income 18 Total other income, net 7,545 1,023 14,483 1,698 Net loss $ $ $ $ Net loss per share, basic and diluted $ $ $ $ Weighted average shares of common stock, basic and diluted 121,680,844 108,644,329 121,501,849 108,469,760 Other comprehensive loss: Unrealized holding ga...",
"X FGFR1 FGFR2 FGFR3 FGFR4"
07/31/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/31/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/31/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/31/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/10/2023 SC 13G/A FMR LLC reports a 2.4% stake in RELAY THERAPEUTICS INC
06/28/2023 4 Rahmer Peter (See remarks) has filed a Form 4 on Relay Therapeutics, Inc.
Txns: Sold 244 shares @ $12.12, valued at $3k
06/28/2023 4 Catinazzo Thomas (CFO) has filed a Form 4 on Relay Therapeutics, Inc.
Txns: Sold 294 shares @ $12.12, valued at $3.6k
06/28/2023 4 Bergstrom Donald A (President, R&D) has filed a Form 4 on Relay Therapeutics, Inc.
Txns: Sold 647 shares @ $12.12, valued at $7.8k
06/28/2023 4 Adams Brian (Chief Legal Officer) has filed a Form 4 on Relay Therapeutics, Inc.
Txns: Sold 294 shares @ $12.12, valued at $3.6k
06/01/2023 4 HILL LINDA A (Director) has filed a Form 4 on Relay Therapeutics, Inc.
Txns: Granted 66,055 options to buy @ $11.14, valued at $735.9k
06/01/2023 4 INGRAM DOUGLAS S (Director) has filed a Form 4 on Relay Therapeutics, Inc.
Txns: Granted 66,055 options to buy @ $11.14, valued at $735.9k
06/01/2023 4 Kathiresan Sekar (Director) has filed a Form 4 on Relay Therapeutics, Inc.
Txns: Granted 66,055 options to buy @ $11.14, valued at $735.9k
06/01/2023 4 Murcko Mark (Director) has filed a Form 4 on Relay Therapeutics, Inc.
Txns: Granted 66,055 options to buy @ $11.14, valued at $735.9k
06/01/2023 4 Rubin Jami (Director) has filed a Form 4 on Relay Therapeutics, Inc.
Txns: Granted 66,055 options to buy @ $11.14, valued at $735.9k
06/01/2023 4 Shawver Laura (Director) has filed a Form 4 on Relay Therapeutics, Inc.
Txns: Granted 66,055 options to buy @ $11.14, valued at $735.9k
06/01/2023 4 Borisy Alexis (Director) has filed a Form 4 on Relay Therapeutics, Inc.
Txns: Granted 66,055 options to buy @ $11.14, valued at $735.9k
06/01/2023 4 Rahmer Peter (See remarks) has filed a Form 4 on Relay Therapeutics, Inc.
Txns: Granted 161,818 shares @ $0
06/01/2023 4/A Rahmer Peter (See remarks) has filed a Form 4 on Relay Therapeutics, Inc.
Txns: Sold 1,657 shares @ $11.16, valued at $18.5k
06/01/2023 4/A Catinazzo Thomas (CFO) has filed a Form 4 on Relay Therapeutics, Inc.
Txns: Sold 2,012 shares @ $11.16, valued at $22.5k
06/01/2023 4/A Bergstrom Donald A (President, R&D) has filed a Form 4 on Relay Therapeutics, Inc.
Txns: Sold 2,850 shares @ $11.16, valued at $31.8k
06/01/2023 4/A Adams Brian (Chief Legal Officer) has filed a Form 4 on Relay Therapeutics, Inc.
Txns: Sold 1,936 shares @ $11.16, valued at $21.6k
05/31/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
05/26/2023 4 Shawver Laura (Director) has filed a Form 4 on Relay Therapeutics, Inc.
Txns: Gifted 12,099 shares @ $0
05/25/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Media: Dan Budwick 1AB 973-271-6085 [email protected] 4"
05/04/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/04/2023 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy